13,690 Shares in Tempus AI, Inc. $TEM Purchased by Balefire LLC

Key Points

• Balefire LLC acquired 13,690 shares of Tempus AI, Inc. valued at approximately $870,000, according to a recent SEC filing.
• Insiders at Tempus AI have sold 601,787 shares worth around $42.5 million over the past three months, with executives Andrew Polovin and James William Rogers making notable transactions.
• Tempus AI reported a quarterly revenue increase of 89.5% year-over-year, with earnings per share at ($0.22), surpassing analysts' expectations of ($0.23).

Balefire LLC purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 13,690 shares of the company's stock, valued at approximately $870,000.

Several other large investors also recently modified their holdings of TEM. Cherry Tree Wealth Management LLC purchased a new stake in shares of Tempus AI during the 1st quarter worth approximately $31,000. University of Texas Texas AM Investment Management Co. purchased a new stake in Tempus AI in the first quarter worth $33,000. Continuum Advisory LLC purchased a new stake in Tempus AI in the first quarter worth $39,000. Bartlett & CO. Wealth Management LLC increased its position in Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock worth $39,000 after buying an additional 400 shares during the last quarter. Finally, Nemes Rush Group LLC purchased a new stake in Tempus AI in the 1st quarter worth about $39,000. Hedge funds and other institutional investors own 24.22% of the company's stock.

Insider Activity

In related news, EVP Andrew Polovin sold 5,398 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total transaction of $402,960.70. Following the completion of the transaction, the executive vice president directly owned 132,056 shares in the company, valued at $9,857,980.40. The trade was a 3.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO James William Rogers sold 7,528 shares of the business's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $561,965.20. Following the transaction, the chief financial officer owned 138,473 shares of the company's stock, valued at approximately $10,337,009.45. The trade was a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 601,787 shares of company stock worth $42,492,268. Company insiders own 26.27% of the company's stock.

Tempus AI Price Performance

Shares of NASDAQ:TEM opened at $87.04 on Wednesday. The company has a 50 day moving average of $68.72 and a 200 day moving average of $60.01. The stock has a market cap of $15.12 billion, a P/E ratio of -73.14 and a beta of 5.08. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month high of $91.45. The company has a current ratio of 1.54, a quick ratio of 1.43 and a debt-to-equity ratio of 2.58.

Tempus AI (NASDAQ:TEM - Get Free Report) last issued its quarterly earnings data on Friday, August 8th. The company reported ($0.22) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.01. The company had revenue of $314.64 million during the quarter, compared to analysts' expectations of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. Tempus AI's revenue for the quarter was up 89.5% on a year-over-year basis. During the same quarter in the previous year, the company earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. As a group, sell-side analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on TEM. BTIG Research lifted their price objective on Tempus AI from $75.00 to $85.00 and gave the stock a "buy" rating in a report on Wednesday, August 20th. Bank of America lifted their target price on shares of Tempus AI from $68.00 to $70.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 25th. Needham & Company LLC reiterated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research note on Friday, August 8th. HC Wainwright lifted their price objective on shares of Tempus AI from $90.00 to $98.00 and gave the company a "buy" rating in a research note on Friday, September 12th. Finally, Piper Sandler reiterated a "neutral" rating on shares of Tempus AI in a research note on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Tempus AI presently has an average rating of "Moderate Buy" and a consensus price target of $70.17.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.